Insiders Buying Solid Biosciences And 2 Other Stocks
Insiders Buying Solid Biosciences And 2 Other Stocks
Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.
尽管周五美国股市收盘涨跌互现，但仍有一些值得注意的内幕交易。
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
当内部人士购买股票时，这表明他们对公司前景充满信心，或者他们认为股票很划算。无论哪种方式，这都预示着做多该股的机会。不应将内幕购买视为做出投资或交易决策的唯一指标。充其量，它可以为购买决定提供信心。
Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.
以下是最近一些值得注意的内幕收购。欲了解更多，请查看 本辛加的内幕交易 平台。
Solid Biosciences
固体生物科学
- The Trade: Solid Biosciences Inc. (NASDAQ:SLDB) Director Joseph Edelman acquired a total of 3,410,713 shares an average price of $5.53. To acquire these shares, it cost around $18.86 million. The company's 10% owner RA Capital Nexus Fund, L.P also bought 904,160 shares at an average price of $5.53.
- What's Happening: Solid Biosciences entered into a securities purchase agreement with a select group of institutional accredited investors for an approximately $108.9 million private placement.
- What Solid Biosciences Does: Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs.
- 交易：Solid Biosciences Inc.（纳斯达克股票代码：SLDB）董事约瑟夫·爱德曼 共收购了3,410,713股股票 平均价格为5.53美元。收购这些股票的成本约为1886万美元。该公司10％的所有者RA Capital Nexus Fund, L.P还以5.53美元的平均价格购买了904,160股股票。
- 发生了什么：Solid Biosciences与一批精选的机构认可投资者签订了证券购买协议，进行约1.089亿美元的私募融资。
- Solid Biosciences 做什么：Solid Biosciences Inc 是一家生命科学公司。它从事特种药物和仿制药的制造。
Champions Oncology
肿瘤学冠军
- The Trade: Champions Oncology, Inc. (NASDAQ:CSBR) Director Daniel Mendelson acquired a total of 2,000 shares at an average price of $6.27. To acquire these shares, it cost around $12,540.
- What's Happening: Champions Oncology, last month, posted a loss for the second quarter.
- What Champions Oncology Does: Champions Oncology Inc is a us-based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs.
- 交易：Champions Oncology, Inc.（纳斯达克股票代码：CSBR）董事丹尼尔·门德尔森共收购了2,000股股票，平均价格为6.27美元。收购这些股票的成本约为12,540美元。
- 发生了什么：Champions Oncology上个月公布了第二季度亏损。
- Champions Oncology做什么：Champions Oncology Inc是一家总部位于美国的公司，致力于开发和销售先进的技术解决方案和产品，以实现肿瘤药物的个性化开发和使用。
Don't forget to check out our premarket coverage here
别忘了在这里查看我们的上市前报道
AMREP
AMREP
- The Trade: AMREP Corporation (NYSE:AXR) 10% owner Rainey Lancaster bought a total of 6,800 shares at an average price of $21.93. To acquire these shares, it cost around $149,120.
- What's Happening: Amrep, last month, reported a decline in quarterly sales.
- What AMREP Does: Amrep Corp through its subsidiaries is engaged in the Real estate business.
- 交易：AMREP 公司（纽约证券交易所代码：AXR）10% 的所有者雷尼·兰开斯特 共购买了6,800股股票 平均价格为21.93美元。收购这些股票的成本约为149,120美元。
- 发生了什么：Amrep上个月报告了季度销售额的下降。
- AMREP的所作所为：Amrep Corp通过其子公司从事房地产业务。
Check This Out: Top 4 Tech And Telecom Stocks That May Crash In January
看看这个： 一月份可能暴跌的四大科技和电信股票